洛陽玻璃(600876.SH):擬受讓北方玻璃及晶華玻璃的控股股權 二者擬建光伏玻璃生產項目
格隆匯12月30日丨洛陽玻璃(600876.SH)公佈,公司與關聯方中國耀華玻璃集團有限公司(“耀華集團”)、凱盛玻璃控股有限公司(“凱盛控股”)分別簽訂了《合作框架協議》,就相關合作事項達成共識。
目前,耀華集團持有秦皇島北方玻璃有限公司(“北方玻璃”)100%股權,凱盛控股持有凱盛晶華玻璃有限公司(“晶華玻璃”)100%股權,北方玻璃和晶華玻璃擬建設光伏玻璃生產項目(“新建項目”),考慮到新建項目投產後將與公司產生同業競爭,為規範和避免同業競爭,根據協議,耀華集團同意將其下屬北方玻璃的控股股權轉讓予公司、凱盛控股同意將其下屬晶華玻璃的控股股權轉讓予公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.